1	Immunological	_	JJ	_	_	2	NMOD	_	_
2	tolerance	_	NN	_	_	5	VMOD	_	_
3	to	_	TO	_	_	2	NMOD	_	_
4	self-antigens	_	NNS	_	_	3	PMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	result	_	NN	_	_	5	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	deletion	_	NN	_	_	8	PMOD	_	_
11	of	_	IN	_	_	10	NMOD	_	_
12	self-reactive	_	JJ	_	_	14	NMOD	_	_
13	T	_	NN	_	_	14	NMOD	_	_
14	lymphocytes	_	NNS	_	_	11	PMOD	_	_
15	in	_	IN	_	_	14	NMOD	_	_
16	the	_	DT	_	_	17	NMOD	_	_
17	thymus	_	NN	_	_	15	PMOD	_	_
18	(	_	(	_	_	20	P	_	_
19	central	_	JJ	_	_	20	NMOD	_	_
20	tolerance	_	NN	_	_	17	PRN	_	_
21	)	_	)	_	_	20	P	_	_
22	and	_	CC	_	_	7	COORD	_	_
23	suppression	_	NN	_	_	22	CONJ	_	_
24	of	_	IN	_	_	23	NMOD	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	activation	_	NN	_	_	24	PMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	potentially	_	RB	_	_	29	AMOD	_	_
29	self-reactive	_	JJ	_	_	31	NMOD	_	_
30	T	_	NN	_	_	31	NMOD	_	_
31	lymphocytes	_	NNS	_	_	27	PMOD	_	_
32	in	_	IN	_	_	26	NMOD	_	_
33	the	_	DT	_	_	34	NMOD	_	_
34	periphery	_	NN	_	_	32	PMOD	_	_
35	(	_	(	_	_	37	P	_	_
36	peripheral	_	JJ	_	_	37	NMOD	_	_
37	tolerance	_	NN	_	_	34	PRN	_	_
38	)	_	)	_	_	37	P	_	_
39	[	_	(	_	_	40	P	_	_
40	1	_	CD	_	_	5	PRN	_	_
41	]	_	)	_	_	40	P	_	_
42	.	_	.	_	_	5	P	_	_
		
1	Suppression	_	NN	_	_	7	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	pathogenic	_	JJ	_	_	6	NMOD	_	_
4	T	_	NN	_	_	6	NMOD	_	_
5	cell	_	NN	_	_	6	NMOD	_	_
6	responses	_	NNS	_	_	2	PMOD	_	_
7	is	_	VBZ	_	_	0	ROOT	_	_
8	mediated	_	VBN	_	_	7	VC	_	_
9	by	_	IN	_	_	8	VMOD	_	_
10	naturally	_	RB	_	_	11	AMOD	_	_
11	arising	_	VBG	_	_	15	NMOD	_	_
12	CD4+CD25+	_	NN	_	_	15	NMOD	_	_
13	T	_	NN	_	_	15	NMOD	_	_
14	regulatory	_	JJ	_	_	15	NMOD	_	_
15	cells	_	NNS	_	_	9	PMOD	_	_
16	(	_	(	_	_	17	P	_	_
17	Tregs	_	NNS	_	_	15	PRN	_	_
18	)	_	)	_	_	17	P	_	_
19	[	_	(	_	_	20	P	_	_
20	2,3	_	NN	_	_	15	PRN	_	_
21	]	_	)	_	_	20	P	_	_
22	.	_	.	_	_	7	P	_	_
		
1	Deficiencies	_	NNS	_	_	7	VMOD	_	_
2	in	_	IN	_	_	1	NMOD	_	_
3	Treg	_	NN	_	_	4	NMOD	_	_
4	development	_	NN	_	_	2	PMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	function	_	NN	_	_	5	CONJ	_	_
7	have	_	VBP	_	_	0	ROOT	_	_
8	been	_	VBN	_	_	7	VC	_	_
9	linked	_	VBN	_	_	8	VC	_	_
10	to	_	TO	_	_	9	VMOD	_	_
11	the	_	DT	_	_	14	NMOD	_	_
12	severe	_	JJ	_	_	14	NMOD	_	_
13	autoimmune	_	JJ	_	_	14	NMOD	_	_
14	disorder	_	NN	_	_	10	PMOD	_	_
15	known	_	VBN	_	_	14	APPO	_	_
16	as	_	IN	_	_	15	VMOD	_	_
17	immune	_	JJ	_	_	18	NMOD	_	_
18	dysregulation	_	NN	_	_	16	PMOD	_	_
19	,	_	,	_	_	18	P	_	_
20	polyendocrinopathy	_	NN	_	_	18	COORD	_	_
21	,	_	,	_	_	20	P	_	_
22	enteropathy	_	NN	_	_	20	COORD	_	_
23	,	_	,	_	_	22	P	_	_
24	X-linked	_	JJ	_	_	25	NMOD	_	_
25	syndrome	_	NN	_	_	22	COORD	_	_
26	(	_	(	_	_	27	P	_	_
27	IPEX	_	NN	_	_	25	PRN	_	_
28	)	_	)	_	_	27	P	_	_
29	[	_	(	_	_	30	P	_	_
30	4	_	CD	_	_	9	PRN	_	_
31	]	_	)	_	_	30	P	_	_
32	.	_	.	_	_	7	P	_	_
		
1	In	_	IN	_	_	6	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	6	P	_	_
4	recent	_	JJ	_	_	5	NMOD	_	_
5	studies	_	NNS	_	_	6	VMOD	_	_
6	have	_	VBP	_	_	0	ROOT	_	_
7	provided	_	VBN	_	_	6	VC	_	_
8	strong	_	JJ	_	_	9	NMOD	_	_
9	evidence	_	NN	_	_	7	VMOD	_	_
10	that	_	IN	_	_	9	NMOD	_	_
11	dysregulation	_	NN	_	_	17	VMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	Treg	_	NN	_	_	14	NMOD	_	_
14	development	_	NN	_	_	12	PMOD	_	_
15	and/or	_	CC	_	_	14	COORD	_	_
16	function	_	NN	_	_	15	CONJ	_	_
17	may	_	MD	_	_	10	SUB	_	_
18	be	_	VB	_	_	17	VC	_	_
19	a	_	DT	_	_	21	NMOD	_	_
20	significant	_	JJ	_	_	21	NMOD	_	_
21	factor	_	NN	_	_	18	VMOD	_	_
22	in	_	IN	_	_	18	VMOD	_	_
23	the	_	DT	_	_	24	NMOD	_	_
24	pathogenesis	_	NN	_	_	22	PMOD	_	_
25	of	_	IN	_	_	24	NMOD	_	_
26	several	_	JJ	_	_	28	NMOD	_	_
27	autoimmune	_	JJ	_	_	28	NMOD	_	_
28	disorders	_	NNS	_	_	25	PMOD	_	_
29	(	_	(	_	_	30	P	_	_
30	e.g.	_	FW	_	_	28	PRN	_	_
31	,	_	,	_	_	30	P	_	_
32	multiple	_	JJ	_	_	33	NMOD	_	_
33	sclerosis	_	NN	_	_	30	PMOD	_	_
34	[	_	(	_	_	35	P	_	_
35	5	_	CD	_	_	33	PRN	_	_
36	]	_	)	_	_	35	P	_	_
37	,	_	,	_	_	33	P	_	_
38	myasthenia	_	NN	_	_	39	NMOD	_	_
39	gravis	_	NN	_	_	33	COORD	_	_
40	[	_	(	_	_	41	P	_	_
41	6	_	CD	_	_	39	PRN	_	_
42	]	_	)	_	_	41	P	_	_
43	,	_	,	_	_	39	P	_	_
44	and	_	CC	_	_	39	COORD	_	_
45	type	_	NN	_	_	47	NMOD	_	_
46	1	_	CD	_	_	47	NMOD	_	_
47	diabetes	_	NN	_	_	44	CONJ	_	_
48	[	_	(	_	_	49	P	_	_
49	7	_	CD	_	_	47	PRN	_	_
50	]	_	)	_	_	49	P	_	_
51	)	_	)	_	_	30	P	_	_
52	and	_	CC	_	_	28	COORD	_	_
53	virus-induced	_	JJ	_	_	55	NMOD	_	_
54	immunologic	_	JJ	_	_	55	NMOD	_	_
55	disorders	_	NNS	_	_	52	CONJ	_	_
56	(	_	(	_	_	57	P	_	_
57	e.g.	_	FW	_	_	55	PRN	_	_
58	,	_	,	_	_	57	P	_	_
59	human	_	JJ	_	_	63	NMOD	_	_
60	T	_	NN	_	_	63	NMOD	_	_
61	lymphotropic	_	NN	_	_	63	NMOD	_	_
62	virus	_	NN	_	_	63	NMOD	_	_
63	type	_	NN	_	_	68	AMOD	_	_
64	I	_	CD	_	_	63	NMOD	_	_
65	[	_	(	_	_	66	P	_	_
66	HTLV-I	_	NN	_	_	63	PRN	_	_
67	]	_	)	_	_	66	P	_	_
68	-associated	_	JJ	_	_	71	NMOD	_	_
69	myelopathy/tropical	_	JJ	_	_	71	NMOD	_	_
70	spastic	_	JJ	_	_	71	NMOD	_	_
71	paraparesis	_	NN	_	_	57	PMOD	_	_
72	[	_	(	_	_	73	P	_	_
73	HAM/TSP	_	NN	_	_	71	PRN	_	_
74	]	_	)	_	_	73	P	_	_
75	,	_	,	_	_	71	P	_	_
76	and	_	CC	_	_	71	COORD	_	_
77	HIV-induced	_	JJ	_	_	78	NMOD	_	_
78	AIDS	_	NN	_	_	76	CONJ	_	_
79	[	_	(	_	_	80	P	_	_
80	8-10	_	CD	_	_	78	PRN	_	_
81	]	_	)	_	_	80	P	_	_
82	)	_	)	_	_	57	P	_	_
83	.	_	.	_	_	6	P	_	_
		
1	The	_	DT	_	_	4	NMOD	_	_
2	transcription	_	NN	_	_	4	NMOD	_	_
3	factor	_	NN	_	_	4	NMOD	_	_
4	Foxp3	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	a	_	DT	_	_	12	NMOD	_	_
7	431-amino	_	JJ	_	_	12	NMOD	_	_
8	acid	_	NN	_	_	12	NMOD	_	_
9	(	_	(	_	_	12	P	_	_
10	48-kDa	_	JJ	_	_	12	NMOD	_	_
11	)	_	)	_	_	12	P	_	_
12	protein	_	NN	_	_	5	VMOD	_	_
13	expressed	_	VBN	_	_	12	APPO	_	_
14	at	_	IN	_	_	13	VMOD	_	_
15	very	_	RB	_	_	16	AMOD	_	_
16	high	_	JJ	_	_	17	NMOD	_	_
17	levels	_	NNS	_	_	14	PMOD	_	_
18	in	_	IN	_	_	17	NMOD	_	_
19	CD4+CD25hi	_	NN	_	_	21	NMOD	_	_
20	T	_	NN	_	_	21	NMOD	_	_
21	cells	_	NNS	_	_	18	PMOD	_	_
22	and	_	CC	_	_	5	COORD	_	_
23	has	_	VBZ	_	_	22	CONJ	_	_
24	previously	_	RB	_	_	23	VMOD	_	_
25	been	_	VBN	_	_	23	VC	_	_
26	shown	_	VBN	_	_	25	VC	_	_
27	to	_	TO	_	_	26	VMOD	_	_
28	be	_	VB	_	_	27	IM	_	_
29	absolutely	_	RB	_	_	28	VMOD	_	_
30	critical	_	JJ	_	_	28	VMOD	_	_
31	for	_	IN	_	_	30	AMOD	_	_
32	Treg	_	NN	_	_	33	NMOD	_	_
33	development	_	NN	_	_	31	PMOD	_	_
34	and	_	CC	_	_	33	COORD	_	_
35	function	_	NN	_	_	34	CONJ	_	_
36	[	_	(	_	_	35	P	_	_
37	11-14	_	CD	_	_	35	NMOD	_	_
38	]	_	)	_	_	35	P	_	_
39	.	_	.	_	_	5	P	_	_
		
1	Foxp3	_	NN	_	_	2	VMOD	_	_
2	contains	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	6	NMOD	_	_
4	proline-rich	_	JJ	_	_	6	NMOD	_	_
5	amino-terminal	_	JJ	_	_	6	NMOD	_	_
6	domain	_	NN	_	_	2	VMOD	_	_
7	reported	_	VBN	_	_	6	APPO	_	_
8	to	_	TO	_	_	7	VMOD	_	_
9	function	_	VB	_	_	8	IM	_	_
10	as	_	IN	_	_	9	VMOD	_	_
11	a	_	DT	_	_	13	NMOD	_	_
12	nuclear	_	JJ	_	_	13	NMOD	_	_
13	factor	_	NN	_	_	10	PMOD	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	activated	_	VBN	_	_	17	NMOD	_	_
16	T	_	NN	_	_	17	NMOD	_	_
17	cells	_	NNS	_	_	14	PMOD	_	_
18	(	_	(	_	_	19	P	_	_
19	NF-AT	_	NN	_	_	13	PRN	_	_
20	)	_	)	_	_	19	P	_	_
21	and	_	CC	_	_	13	COORD	_	_
22	nuclear	_	JJ	_	_	28	NMOD	_	_
23	factor-kappaB	_	NN	_	_	28	NMOD	_	_
24	(	_	(	_	_	28	P	_	_
25	NF-kappaB	_	NN	_	_	28	NMOD	_	_
26	)	_	)	_	_	28	P	_	_
27	binding	_	NN	_	_	28	NMOD	_	_
28	domain	_	NN	_	_	21	CONJ	_	_
29	,	_	,	_	_	6	P	_	_
30	a	_	DT	_	_	32	NMOD	_	_
31	central	_	JJ	_	_	32	NMOD	_	_
32	region	_	NN	_	_	6	COORD	_	_
33	containing	_	VBG	_	_	32	APPO	_	_
34	a	_	DT	_	_	36	NMOD	_	_
35	zinc	_	NN	_	_	36	NMOD	_	_
36	finger	_	NN	_	_	33	VMOD	_	_
37	and	_	CC	_	_	36	COORD	_	_
38	leucine	_	NN	_	_	39	NMOD	_	_
39	zipper	_	NN	_	_	37	CONJ	_	_
40	potentially	_	RB	_	_	41	AMOD	_	_
41	important	_	JJ	_	_	36	APPO	_	_
42	for	_	IN	_	_	41	AMOD	_	_
43	protein-protein	_	JJ	_	_	44	NMOD	_	_
44	interactions	_	NNS	_	_	42	PMOD	_	_
45	,	_	,	_	_	32	P	_	_
46	and	_	CC	_	_	32	COORD	_	_
47	a	_	DT	_	_	53	NMOD	_	_
48	carboxyl-terminal	_	JJ	_	_	53	NMOD	_	_
49	forkhead	_	NN	_	_	53	NMOD	_	_
50	(	_	(	_	_	53	P	_	_
51	FKH	_	NN	_	_	53	NMOD	_	_
52	)	_	)	_	_	53	P	_	_
53	domain	_	NN	_	_	46	CONJ	_	_
54	required	_	VBN	_	_	53	APPO	_	_
55	for	_	IN	_	_	54	VMOD	_	_
56	nuclear	_	JJ	_	_	57	NMOD	_	_
57	localization	_	NN	_	_	55	PMOD	_	_
58	and	_	CC	_	_	57	COORD	_	_
59	DNA-binding	_	JJ	_	_	60	NMOD	_	_
60	activity	_	NN	_	_	58	CONJ	_	_
61	[	_	(	_	_	62	P	_	_
62	14-16	_	CD	_	_	60	PRN	_	_
63	]	_	)	_	_	62	P	_	_
64	.	_	.	_	_	2	P	_	_
		
1	Functional	_	JJ	_	_	2	NMOD	_	_
2	inactivation	_	NN	_	_	39	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	Foxp3	_	NN	_	_	3	PMOD	_	_
5	by	_	IN	_	_	2	NMOD	_	_
6	genetic	_	JJ	_	_	7	NMOD	_	_
7	mutations	_	NNS	_	_	5	PMOD	_	_
8	affecting	_	VBG	_	_	7	APPO	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	Foxp3	_	NN	_	_	12	NMOD	_	_
11	coding	_	NN	_	_	12	NMOD	_	_
12	region	_	NN	_	_	8	VMOD	_	_
13	,	_	,	_	_	14	P	_	_
14	as	_	IN	_	_	12	PRN	_	_
15	demonstrated	_	VBN	_	_	14	SUB	_	_
16	in	_	IN	_	_	15	VMOD	_	_
17	IPEX	_	NN	_	_	16	PMOD	_	_
18	,	_	,	_	_	14	P	_	_
19	or	_	CC	_	_	12	COORD	_	_
20	repression	_	NN	_	_	19	CONJ	_	_
21	of	_	IN	_	_	20	NMOD	_	_
22	Foxp3	_	NN	_	_	23	NMOD	_	_
23	expression	_	NN	_	_	21	PMOD	_	_
24	by	_	IN	_	_	20	NMOD	_	_
25	the	_	DT	_	_	29	NMOD	_	_
26	HTLV-I-encoded	_	JJ	_	_	29	NMOD	_	_
27	transactivator	_	NN	_	_	29	NMOD	_	_
28	protein	_	NN	_	_	29	NMOD	_	_
29	Tax	_	NN	_	_	24	PMOD	_	_
30	,	_	,	_	_	2	P	_	_
31	as	_	IN	_	_	2	NMOD	_	_
32	recently	_	RB	_	_	33	VMOD	_	_
33	reported	_	VBN	_	_	31	SUB	_	_
34	in	_	IN	_	_	33	VMOD	_	_
35	patients	_	NNS	_	_	34	PMOD	_	_
36	with	_	IN	_	_	35	NMOD	_	_
37	HAM/TSP	_	NN	_	_	36	PMOD	_	_
38	,	_	,	_	_	2	P	_	_
39	results	_	VBZ	_	_	0	ROOT	_	_
40	in	_	IN	_	_	39	VMOD	_	_
41	loss	_	NN	_	_	40	PMOD	_	_
42	of	_	IN	_	_	41	NMOD	_	_
43	regulatory	_	JJ	_	_	44	NMOD	_	_
44	activity	_	NN	_	_	42	PMOD	_	_
45	in	_	IN	_	_	44	NMOD	_	_
46	CD4+CD25hi	_	NN	_	_	48	NMOD	_	_
47	T	_	NN	_	_	48	NMOD	_	_
48	cells	_	NNS	_	_	45	PMOD	_	_
49	[	_	(	_	_	50	P	_	_
50	4,8,17	_	NN	_	_	48	PRN	_	_
51	]	_	)	_	_	50	P	_	_
52	.	_	.	_	_	39	P	_	_
		
1	Although	_	IN	_	_	17	VMOD	_	_
2	it	_	PRP	_	_	3	VMOD	_	_
3	is	_	VBZ	_	_	1	SUB	_	_
4	clear	_	JJ	_	_	3	VMOD	_	_
5	that	_	IN	_	_	3	VMOD	_	_
6	Foxp3	_	NN	_	_	7	VMOD	_	_
7	regulates	_	VBZ	_	_	5	SUB	_	_
8	T	_	NN	_	_	10	NMOD	_	_
9	cell	_	NN	_	_	10	NMOD	_	_
10	proliferation	_	NN	_	_	7	VMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	cytokine	_	NN	_	_	13	NMOD	_	_
13	production	_	NN	_	_	11	CONJ	_	_
14	,	_	,	_	_	17	P	_	_
15	very	_	RB	_	_	16	NMOD	_	_
16	little	_	JJ	_	_	17	VMOD	_	_
17	is	_	VBZ	_	_	0	ROOT	_	_
18	known	_	VBN	_	_	17	VC	_	_
19	concerning	_	VBG	_	_	18	VMOD	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	molecular	_	JJ	_	_	22	NMOD	_	_
22	mechanisms	_	NNS	_	_	19	VMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	Foxp3	_	NN	_	_	25	NMOD	_	_
25	function	_	NN	_	_	23	PMOD	_	_
26	.	_	.	_	_	17	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	first	_	JJ	_	_	3	NMOD	_	_
3	evidence	_	NN	_	_	17	VMOD	_	_
4	to	_	TO	_	_	3	APPO	_	_
5	indicate	_	VB	_	_	4	IM	_	_
6	how	_	WRB	_	_	8	VMOD	_	_
7	Foxp3	_	NN	_	_	8	VMOD	_	_
8	promotes	_	VBZ	_	_	5	VMOD	_	_
9	the	_	DT	_	_	10	NMOD	_	_
10	development	_	NN	_	_	8	VMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	function	_	NN	_	_	11	CONJ	_	_
13	of	_	IN	_	_	10	NMOD	_	_
14	regulatory	_	JJ	_	_	16	NMOD	_	_
15	T	_	NN	_	_	16	NMOD	_	_
16	cells	_	NNS	_	_	13	PMOD	_	_
17	came	_	VBD	_	_	0	ROOT	_	_
18	from	_	IN	_	_	17	VMOD	_	_
19	a	_	DT	_	_	20	NMOD	_	_
20	report	_	NN	_	_	18	PMOD	_	_
21	by	_	IN	_	_	17	VMOD	_	_
22	Ziegler	_	NNP	_	_	21	PMOD	_	_
23	and	_	CC	_	_	22	COORD	_	_
24	colleagues	_	NNS	_	_	23	CONJ	_	_
25	[	_	(	_	_	26	P	_	_
26	16	_	CD	_	_	22	PRN	_	_
27	]	_	)	_	_	26	P	_	_
28	,	_	,	_	_	22	P	_	_
29	which	_	WDT	_	_	30	VMOD	_	_
30	suggested	_	VBD	_	_	22	NMOD	_	_
31	that	_	IN	_	_	30	VMOD	_	_
32	Foxp3	_	NN	_	_	33	VMOD	_	_
33	could	_	MD	_	_	31	SUB	_	_
34	inhibit	_	VB	_	_	33	VC	_	_
35	transcriptional	_	JJ	_	_	36	NMOD	_	_
36	activation	_	NN	_	_	34	VMOD	_	_
37	by	_	IN	_	_	34	VMOD	_	_
38	physically	_	RB	_	_	39	VMOD	_	_
39	interacting	_	VBG	_	_	37	PMOD	_	_
40	with	_	IN	_	_	39	VMOD	_	_
41	forkhead	_	NN	_	_	43	NMOD	_	_
42	binding	_	NN	_	_	43	NMOD	_	_
43	sites	_	NNS	_	_	40	PMOD	_	_
44	located	_	JJ	_	_	46	AMOD	_	_
45	immediately	_	RB	_	_	46	AMOD	_	_
46	adjacent	_	JJ	_	_	43	APPO	_	_
47	to	_	TO	_	_	46	AMOD	_	_
48	critical	_	JJ	_	_	52	NMOD	_	_
49	cis-acting	_	JJ	_	_	52	NMOD	_	_
50	NF-AT	_	NN	_	_	52	NMOD	_	_
51	binding	_	NN	_	_	52	NMOD	_	_
52	sites	_	NNS	_	_	47	PMOD	_	_
53	found	_	VBN	_	_	52	APPO	_	_
54	in	_	IN	_	_	53	VMOD	_	_
55	various	_	JJ	_	_	57	NMOD	_	_
56	cytokine	_	NN	_	_	57	NMOD	_	_
57	promoters	_	NNS	_	_	54	PMOD	_	_
58	(	_	(	_	_	62	P	_	_
59	e.g.	_	FW	_	_	62	DEP	_	_
60	,	_	,	_	_	62	P	_	_
61	IL-2	_	NN	_	_	62	NMOD	_	_
62	promoter	_	NN	_	_	57	PRN	_	_
63	)	_	)	_	_	62	P	_	_
64	.	_	.	_	_	17	P	_	_
		
1	That	_	DT	_	_	2	NMOD	_	_
2	study	_	NN	_	_	4	VMOD	_	_
3	also	_	RB	_	_	4	VMOD	_	_
4	demonstrated	_	VBD	_	_	0	ROOT	_	_
5	that	_	IN	_	_	4	VMOD	_	_
6	Foxp3	_	NN	_	_	7	VMOD	_	_
7	could	_	MD	_	_	5	SUB	_	_
8	repress	_	VB	_	_	7	VC	_	_
9	activation	_	NN	_	_	8	VMOD	_	_
10	of	_	IN	_	_	9	NMOD	_	_
11	a	_	DT	_	_	14	NMOD	_	_
12	synthetic	_	JJ	_	_	14	NMOD	_	_
13	reporter	_	NN	_	_	14	NMOD	_	_
14	vector	_	NN	_	_	10	PMOD	_	_
15	containing	_	VBG	_	_	14	APPO	_	_
16	an	_	DT	_	_	18	NMOD	_	_
17	SV40	_	NN	_	_	18	NMOD	_	_
18	promoter	_	NN	_	_	15	VMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	three	_	CD	_	_	22	NMOD	_	_
21	tandem	_	JJ	_	_	22	NMOD	_	_
22	copies	_	NNS	_	_	19	CONJ	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	a	_	DT	_	_	27	NMOD	_	_
25	forkhead	_	NN	_	_	27	NMOD	_	_
26	binding	_	NN	_	_	27	NMOD	_	_
27	site	_	NN	_	_	23	PMOD	_	_
28	.	_	.	_	_	4	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	provided	_	VBD	_	_	0	ROOT	_	_
4	additional	_	JJ	_	_	5	NMOD	_	_
5	evidence	_	NN	_	_	3	VMOD	_	_
6	suggesting	_	VBG	_	_	5	APPO	_	_
7	that	_	IN	_	_	6	VMOD	_	_
8	Foxp3	_	NN	_	_	10	NMOD	_	_
9	transcriptional	_	JJ	_	_	10	NMOD	_	_
10	repression	_	NN	_	_	11	VMOD	_	_
11	was	_	VBD	_	_	7	SUB	_	_
12	mediated	_	VBN	_	_	11	VC	_	_
13	by	_	IN	_	_	12	VMOD	_	_
14	binding	_	VBG	_	_	13	PMOD	_	_
15	in	_	IN	_	_	14	VMOD	_	_
16	a	_	DT	_	_	18	NMOD	_	_
17	sequence-specific	_	JJ	_	_	18	NMOD	_	_
18	manner	_	NN	_	_	15	PMOD	_	_
19	to	_	TO	_	_	14	VMOD	_	_
20	promoters	_	NNS	_	_	19	PMOD	_	_
21	containing	_	VBG	_	_	20	APPO	_	_
22	forkhead	_	NN	_	_	24	NMOD	_	_
23	binding	_	NN	_	_	24	NMOD	_	_
24	sites	_	NNS	_	_	21	VMOD	_	_
25	.	_	.	_	_	3	P	_	_
		
1	A	_	DT	_	_	3	NMOD	_	_
2	recent	_	JJ	_	_	3	NMOD	_	_
3	study	_	NN	_	_	12	VMOD	_	_
4	by	_	IN	_	_	3	NMOD	_	_
5	Bettelli	_	NNP	_	_	4	PMOD	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	colleagues	_	NNS	_	_	6	CONJ	_	_
8	[	_	(	_	_	9	P	_	_
9	15	_	CD	_	_	3	PRN	_	_
10	]	_	)	_	_	9	P	_	_
11	further	_	RB	_	_	12	VMOD	_	_
12	demonstrated	_	VBD	_	_	0	ROOT	_	_
13	that	_	IN	_	_	12	VMOD	_	_
14	Foxp3	_	NN	_	_	15	VMOD	_	_
15	could	_	MD	_	_	13	SUB	_	_
16	inhibit	_	VB	_	_	15	VC	_	_
17	NF-AT	_	NN	_	_	22	NMOD	_	_
18	as	_	RB	_	_	17	COORD	_	_
19	well	_	RB	_	_	18	DEP	_	_
20	as	_	IN	_	_	18	DEP	_	_
21	NF-kappaB	_	NN	_	_	18	CONJ	_	_
22	activation	_	NN	_	_	16	VMOD	_	_
23	,	_	,	_	_	16	P	_	_
24	although	_	IN	_	_	16	VMOD	_	_
25	the	_	DT	_	_	26	NMOD	_	_
26	mechanism	_	NN	_	_	29	VMOD	_	_
27	of	_	IN	_	_	26	NMOD	_	_
28	suppression	_	NN	_	_	27	PMOD	_	_
29	was	_	VBD	_	_	24	SUB	_	_
30	shown	_	VBN	_	_	29	VC	_	_
31	to	_	TO	_	_	30	VMOD	_	_
32	involve	_	VB	_	_	31	IM	_	_
33	direct	_	JJ	_	_	35	NMOD	_	_
34	protein-protein	_	JJ	_	_	35	NMOD	_	_
35	interactions	_	NNS	_	_	32	VMOD	_	_
36	between	_	IN	_	_	35	NMOD	_	_
37	NF-AT	_	NN	_	_	36	PMOD	_	_
38	or	_	CC	_	_	37	COORD	_	_
39	NF-kappaB	_	NN	_	_	38	CONJ	_	_
40	and	_	CC	_	_	39	COORD	_	_
41	Foxp3	_	NN	_	_	42	COORD	_	_
42	rather	_	RB	_	_	40	CONJ	_	_
43	than	_	IN	_	_	42	DEP	_	_
44	binding	_	NN	_	_	42	CONJ	_	_
45	of	_	IN	_	_	44	NMOD	_	_
46	Foxp3	_	NN	_	_	45	PMOD	_	_
47	to	_	TO	_	_	44	NMOD	_	_
48	promoter	_	NN	_	_	49	NMOD	_	_
49	elements	_	NNS	_	_	47	PMOD	_	_
50	adjacent	_	JJ	_	_	49	APPO	_	_
51	to	_	TO	_	_	50	AMOD	_	_
52	cis-acting	_	JJ	_	_	56	NMOD	_	_
53	NF-AT	_	NN	_	_	56	NMOD	_	_
54	or	_	CC	_	_	53	COORD	_	_
55	NF-kappaB	_	NN	_	_	54	CONJ	_	_
56	sites	_	NNS	_	_	51	PMOD	_	_
57	.	_	.	_	_	12	P	_	_
		
1	Collectively	_	RB	_	_	5	VMOD	_	_
2	,	_	,	_	_	5	P	_	_
3	these	_	DT	_	_	4	NMOD	_	_
4	data	_	NNS	_	_	5	VMOD	_	_
5	suggested	_	VBD	_	_	0	ROOT	_	_
6	that	_	IN	_	_	5	VMOD	_	_
7	Foxp3	_	NN	_	_	8	VMOD	_	_
8	may	_	MD	_	_	6	SUB	_	_
9	function	_	VB	_	_	8	VC	_	_
10	as	_	IN	_	_	9	VMOD	_	_
11	a	_	DT	_	_	13	NMOD	_	_
12	transcriptional	_	JJ	_	_	13	NMOD	_	_
13	repressor	_	NN	_	_	10	PMOD	_	_
14	,	_	,	_	_	13	P	_	_
15	potentially	_	RB	_	_	13	APPO	_	_
16	through	_	IN	_	_	15	VMOD	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	formation	_	NN	_	_	16	PMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	both	_	DT	_	_	24	NMOD	_	_
21	DNA-protein	_	JJ	_	_	24	NMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	protein-protein	_	JJ	_	_	22	CONJ	_	_
24	interactions	_	NNS	_	_	19	PMOD	_	_
25	.	_	.	_	_	5	P	_	_
		
1	In	_	IN	_	_	7	VMOD	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	present	_	JJ	_	_	4	NMOD	_	_
4	study	_	NN	_	_	1	PMOD	_	_
5	,	_	,	_	_	7	P	_	_
6	we	_	PRP	_	_	7	VMOD	_	_
7	expanded	_	VBN	_	_	0	ROOT	_	_
8	upon	_	IN	_	_	7	VMOD	_	_
9	these	_	DT	_	_	10	NMOD	_	_
10	observations	_	NNS	_	_	8	PMOD	_	_
11	by	_	IN	_	_	7	VMOD	_	_
12	defining	_	VBG	_	_	11	PMOD	_	_
13	additional	_	JJ	_	_	14	NMOD	_	_
14	requirements	_	NNS	_	_	12	VMOD	_	_
15	of	_	IN	_	_	14	NMOD	_	_
16	Foxp3-mediated	_	JJ	_	_	17	NMOD	_	_
17	repression	_	NN	_	_	15	PMOD	_	_
18	of	_	IN	_	_	17	NMOD	_	_
19	NF-kappaB	_	NN	_	_	20	NMOD	_	_
20	activation	_	NN	_	_	18	PMOD	_	_
21	,	_	,	_	_	7	P	_	_
22	and	_	CC	_	_	7	COORD	_	_
23	investigated	_	VBD	_	_	22	CONJ	_	_
24	whether	_	IN	_	_	23	VMOD	_	_
25	Foxp3	_	NN	_	_	26	VMOD	_	_
26	could	_	MD	_	_	24	SUB	_	_
27	target	_	VB	_	_	26	VC	_	_
28	additional	_	JJ	_	_	30	NMOD	_	_
29	signaling	_	NN	_	_	30	NMOD	_	_
30	pathways	_	NNS	_	_	27	VMOD	_	_
31	by	_	IN	_	_	27	VMOD	_	_
32	examining	_	VBG	_	_	31	PMOD	_	_
33	transcriptional	_	JJ	_	_	34	NMOD	_	_
34	activation	_	NN	_	_	32	VMOD	_	_
35	of	_	IN	_	_	34	NMOD	_	_
36	NF-kappaB-dependent	_	JJ	_	_	40	NMOD	_	_
37	and	_	CC	_	_	36	COORD	_	_
38	NF-kappaB-independent	_	NN	_	_	37	CONJ	_	_
39	retroviral	_	JJ	_	_	38	AMOD	_	_
40	pathogens	_	NNS	_	_	35	PMOD	_	_
41	.	_	.	_	_	7	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	characterization	_	NN	_	_	21	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	the	_	DT	_	_	6	NMOD	_	_
5	molecular	_	JJ	_	_	6	NMOD	_	_
6	targets	_	NNS	_	_	3	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	Foxp3	_	NN	_	_	7	PMOD	_	_
9	and	_	CC	_	_	2	COORD	_	_
10	the	_	DT	_	_	11	NMOD	_	_
11	mechanism(s)	_	NN	_	_	9	CONJ	_	_
12	utilized	_	VBN	_	_	11	APPO	_	_
13	by	_	IN	_	_	12	VMOD	_	_
14	Foxp3	_	NN	_	_	13	PMOD	_	_
15	to	_	TO	_	_	14	APPO	_	_
16	support	_	VB	_	_	15	IM	_	_
17	Treg	_	NN	_	_	18	NMOD	_	_
18	development	_	NN	_	_	16	VMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	function	_	NN	_	_	19	CONJ	_	_
21	will	_	MD	_	_	0	ROOT	_	_
22	aid	_	VB	_	_	21	VC	_	_
23	in	_	IN	_	_	22	VMOD	_	_
24	our	_	PRP$	_	_	25	NMOD	_	_
25	understanding	_	NN	_	_	23	PMOD	_	_
26	of	_	IN	_	_	25	NMOD	_	_
27	the	_	DT	_	_	28	NMOD	_	_
28	role	_	NN	_	_	26	PMOD	_	_
29	Tregs	_	NNS	_	_	30	VMOD	_	_
30	play	_	VBP	_	_	28	NMOD	_	_
31	in	_	IN	_	_	30	VMOD	_	_
32	the	_	DT	_	_	33	NMOD	_	_
33	pathogenesis	_	NN	_	_	31	PMOD	_	_
34	of	_	IN	_	_	33	NMOD	_	_
35	human	_	JJ	_	_	37	NMOD	_	_
36	autoimmune	_	JJ	_	_	37	NMOD	_	_
37	disease	_	NN	_	_	34	PMOD	_	_
38	.	_	.	_	_	21	P	_	_
		
